PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1734890
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1734890
According to Stratistics MRC, the Global Omega-3 Market is accounted for $10.76 billion in 2025 and is expected to reach $31.72 billion by 2032 growing at a CAGR of 16.7% during the forecast period. Omega-3 fatty acids are essential nutrients that support numerous bodily functions, with well-documented benefits for heart, brain, and eye health. Plant sources like flaxseeds and walnuts, as well as fatty fish like salmon and mackerel, are common sources of these polyunsaturated fats. Regular consumption of omega-3 fatty acids is required because the human body is unable to synthesize them effectively. Moreover, studies have demonstrated that omega-3 fatty acids support cardiovascular health, enhance cognitive function, reduce inflammation, and may even reduce the risk of chronic conditions like arthritis and heart disease.
According to the American Heart Association (AHA), omega-3 fatty acids play a significant role in cardiovascular health. The AHA recommends that adults consume at least two servings of fatty fish per week, such as salmon, mackerel, or sardines, to obtain these beneficial nutrients. For individuals with elevated triglyceride levels, the AHA advises a daily intake of 2 to 4 grams of EPA and DHA combined, under medical supervision, to effectively lower triglycerides by 20% to 40%.
Increasing knowledge of health
Omega-3 fatty acids, particularly EPA and DHA, have been thoroughly studied for their role in supporting heart health, reducing inflammation, aiding brain development, and improving vision. Public health campaigns and endorsements from medical organizations like the American Heart Association have further solidified the role of omega-3s in maintaining long-term wellness. As consumers around the world become more health-conscious, there is an increasing demand for preventive healthcare and nutritional solutions. Additionally, this shift toward proactive health management is propelling people to incorporate omega-3 supplements or enriched foods into their daily routine.
High production and final product costs
High-quality omega-3 fatty acid extraction, purification, and stabilization-particularly EPA and DHA-from marine sources are expensive procedures. Supercritical CO2 extraction and molecular distillation are two efficient but costly technologies. Fish from regulated fisheries or algae grown in controlled conditions also raise the cost of production. Omega-3-enriched products and supplements are relatively expensive when compared to other nutritional alternatives because these costs are frequently passed on to consumers. Furthermore, the penetration of the mass market may be restricted by this high price point, especially in developing nations where consumers are price sensitive.
Growing need for omega-3s derived from plants and algae
Demand for non-animal omega-3 sources is rising as veganism and plant-based diets continue to gain popularity around the world. Vegetarians, vegans, and consumers who care about the environment are drawn to algae-derived omega-3s because they provide a sustainable and moral substitute for fish oil. These omega-3s are especially high in DHA. Because algae can be grown in controlled settings, there is less of an impact on the environment and consistency and scalability. Moreover, the expansion of plant-based omega-3 formulations in the food, beverage, and nutraceutical markets is further supported by the growing demand for clean-label products and allergen-free supplements.
High levels of price pressure and market competition
The market is now very competitive, with a mix of big multinational corporations, nutraceutical firms, local suppliers, and private-label brands due to the increasing popularity of omega-3s. As a result, basic omega-3 products have become commoditized, forcing businesses to adopt aggressive pricing strategies. Profit margins are therefore under pressure, particularly for smaller businesses that find it difficult to compete with well-known brands that provide comparable goods at lower prices. Furthermore, in order to stand out, businesses must invest more in branding, innovation, and certifications as product differentiation becomes more challenging.
The COVID-19 pandemic affected the Omega-3 market in a variety of ways, but ultimately for the better. Supply chain interruptions and logistical limitations initially impacted raw material availability, especially fish oil, and caused production and distribution delays. Consumption of dietary supplements, such as Omega-3 products, increased dramatically as the pandemic spread because consumers' priorities changed to immunity, preventive health, and general wellness. Moreover, higher consumption was fuelled by greater knowledge of how EPA and DHA support immune, respiratory, and cardiovascular health, especially through direct-to-consumer and e-commerce channels.
The docosahexaenoic acid (DHA) segment is expected to be the largest during the forecast period
The docosahexaenoic acid (DHA) segment is expected to account for the largest market share during the forecast period because of the vital role it plays in brain development, cognitive function, and visual health, especially in pregnant women and infants. DHA is a common ingredient in baby formulas, prenatal vitamins, and fortified foods. It is also valued in the elderly population for its ability to improve memory and lower the risk of neurodegenerative diseases. Additionally, the most prominent and economically significant market segment is DHA due to its high level of clinical validation and high consumer awareness of its neurological benefits.
The dietary supplements segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the dietary supplements segment is predicted to witness the highest growth rate. The demand for Omega-3 supplements has been driven by rising consumer awareness of the health advantages of Omega-3, such as its beneficial effects on heart health, cognitive function, and inflammation reduction. The aging of the world's population, the growing popularity of fitness and wellness trends, and the growing desire for preventative healthcare all help this market. Furthermore, Omega-3 dietary supplements are very popular due to their ease of use and convenience in the form of gummies, soft gels, and capsules.
During the forecast period, the North America region is expected to hold the largest market share. The high level of consumer awareness of Omega-3's health benefits-particularly for heart health, cognitive function, and inflammation management-fuels this region's prevalence. Moreover, Omega-3 products are easily accessible due to the established healthcare infrastructure in North America. The aging of the population and the growing trend of preventive healthcare further fuel demand for Omega-3 supplements, making North America the region with the biggest and fastest-growing market.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven in nations like China, India, and Japan by rising disposable incomes, growing health consciousness, and growing demand for dietary supplements. Omega-3 product consumption is rising in the region due to the growing middle class and shifting dietary preferences, including a move toward healthier, Western-style diets. Additionally, the growing emphasis on preventive healthcare and the rise of chronic diseases such as cardiovascular conditions are propelling the demand for Omega-3 supplements. The region's market is expanding quickly due in large part to the growth of e-commerce and improved access to foods enriched with omega-3 fatty acids.
Key players in the market
Some of the key players in Omega-3 Market include BASF SE, Rabar Pty Ltd, Croda International Plc, Omega Protein Corporation, ADM, Lonza Group, Kerry Group Plc, Glanbia Plc, Sinomega Biotech Engineering Co. Ltd., Cargill, Incorporated, Algisys LLC, Polaris, Koninklijke DSM N.V., Kinomega Biopharm Inc. and SternVitamin GmbH & Co. KG.
In March 2025, ADM and Mitsubishi Corporation have signed an agreement. This agreement is a non-binding memorandum of understanding. The companies will form a strategic alliance. They will explore potential areas for future collaboration. This collaboration will span the agriculture value chain. The importance of secure food supply chains has increased recently.
In October 2024, BASF, AM Green ink MoU for low-carbon chemical production in India. The agreement was signed by Dr. Markus Kamieth, Chairman of the Board of Executive Directors of BASF SE, and Mahesh Kolli, Group President of AM Green, during the Asia-Pacific Conference of German Business 2024 held in New Delhi.
In March 2024, Croda International has entered a collaboration agreement with the Access to Advanced Health Institute (AAHI) to innovate and develop vaccine adjuvant formulations. Under this deal, the parties will use their combined capabilities to make new vaccine adjuvants accessible worldwide. This approach will aid in the advancement of next-generation vaccines that are robust and durable.